ArticlePloS one2021

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.

Petra Kövy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.